PROPHYLACTIC, DOUBLE BLIND, PLACEBO CONTROLLED RANDOMIZED USE OF HOMEOPATHY FOR PREVENTION OF ATRIAL FIBRILLATION IN PATIENTS WITH AORTOCORONARY BYPASS OR HEART VALVE SURGERY WITH HEART-LUNG MACHINE - Prevention of atrial fibrillatio
Phase 1
- Conditions
- Patients suffering from atrial fibrillation following heart surgery
- Registration Number
- EUCTR2008-002803-17-AT
- Lead Sponsor
- Med. Univ. Wien, Klinik Innere Medizin I, Intensivstation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 238
Inclusion Criteria
Planned heart surgery with heart-lung machine
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age below 18 or beyond 100 years, pregnant patients
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Strychnos Nux vomica prevents atrial fibrillation following heart surgery;Secondary Objective: Influence of Strychos Nux vomica on electrolytes;Primary end point(s): Observational period of 11 days
- Secondary Outcome Measures
Name Time Method